Very poor quality of life with no end in sight. - Recensione dipendente - Senior CRA presso ICON

2,0
15 mag 2012
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Benefits are good. People are for the most part great and the LCRAs have been great to work for.

Svantaggi

Totally metric driven company! 96 days on site per year to receive an avg performance rating. Slip one or two days and you get a below avg rating. Studies are POORLY resourced. Not enough CRA, LCRAs and assistants on every study. CRAs are working 60-75 hours per week and missing metrics due to being over worked and then we suffer at our evalution. The metrics set everyone up for failure. Pfizer alliance only makes this situation worse because of their 483's with the FDA which ICON has a 483 as well. Put two companies like that together and it's all about metrics and unrealistic CAPA committiments to the FDA such as CRAs getting evaluated on a site's EDC entry timeline of 4 CALENDAR days! One vaccine study for Pfizer had 9 of 20 CRAs quit. Which I am too very soon. Rumor is ICON is getting bought out or merging. Employees on all levels are leaving ICON. Oh, no bonuses either and not one drink allowed to be expensed.

Esplora altre recensioni su ICON

5,0
19 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Really great manager. Remote work major plus. No micro management. Great pay

Svantaggi

Annual salary increase this year isn't until September which is odd.

4,0
30 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Strong Leadership, Fair/Average compensation, Thrive Program (company strives to keep you employeed as Sponsor reallocations occur)

Svantaggi

HR is very hands off. It is very difficult to speak to anyone. Not simple to call and ask a question. Everything has to go through a portal. This is challenging when there is time sensitive needs. They make it work but in my opinion, this is a 'con'.

Vedi recensioni per: Utile|Valutazione|Data|Tutto